Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Clonazepam

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Clonazepam Manufacturers in India Suppliers Clonazepam Exporters Distributors Clonazepam api active pharmaceuticals ingredients Clonazepam manufacturers Side Effects bulk drugs raw material Clonazepam companies Side Effects Importers Clonazepam Clonazepam Exporters Clonazepam exporters FDA Clonazepam DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Clonazepam manufacturing pharmaceutical drugs pharmaceutical intermediates Clonazepam pharmaceutical chemicals pharmaceutical raw materials Clonazepam active pharmaceutical ingredients Clonazepam committee active pharmaceutical ingredients manufacturer Clonazepam Active Pharmaceutical Ingredients manufacturer Clonazepam exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Clonazepam, Clonazepam manufacturer India, Clonazepam product, Clonazepam products, Api preparation, Certificate of Analysis API manufacturer product, Clonazepam anti ulcer product, Certificate of Origin COA Clonazepam COS Clonazepam, pharmaceutical generic, pharmaceutical drug, medical, Clonazepam pharma healthcare, pharma patents, contract MSDS manufacturing Trader Clonazepam pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Clonazepam expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Clonazepam DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Clonazepam ingredients, api, HIV Clonazepam, tablets, capsules, syrup & protein Clonazepam powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Clonazepam gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Clonazepam WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Clonazepam

















 

 


 

 





 

 

HOME >> API >> API List1 >> Clonazepam >> Pharmalogy

CAS Number 1622-61-3

PHARMALOGY
Clonazepam CAS Number 1622-61-3

The precise mechanism by which clonazepam exerts its antiseizure and antipanic effects is unknown, although it is believed to be related to its ability to enhance the activity of gamma aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. Convulsions produced in rodents by pentylenetetrazol or, to a lesser extent, electrical stimulation are antagonized, as are convulsions produced by photic stimulation in susceptible baboons. A taming effect in aggressive primates, muscle weakness and hypnosis are also produced. In humans, clonazepam is capable of suppressing the spike and wave discharge in absence seizures (petit mal) and decreasing the frequency, amplitude, duration and spread of discharge in minor motor seizures.

Clonazepam's primary mechanism of action is via modulating GABA function in the brain, via the benzodiazepine receptor which in turn leads to enhanced GABAergic inhibition of neuronal firing. In addition clonazepam decreases the utilization of 5-HT (serotonin) by neuronsand has been shown to bind tightly to central type benzodiazepine receptors.Because of its strong anxiolytic and anticonvulsant properties, it is said to be among the class of "highly potent" benzodiazepines.The anticonvulsant properties of benzodiazepines are due to enhancement of synaptic GABA responses and inhibition of sustained high frequency repetitive firingBenzodiazepines, including clonazepam, bind to mouse glial cell membranes with high affinity.Clonazepam decreases release of acetylcholine in cat brainand decreases prolactin releaseBenzodiazepines inhibit cold-induced thyroid stimulating hormone (also known as TSH or thyrotropin) releaseBenzodiazepines acted via micromolar benzodiazepine binding sites as Ca2+ channel blockers and significantly inhibit depolarization-sensitive calcium uptake in experimentation on rat brain cell components.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
PHARMALOGY >>
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  




Clonazepam

Api Manufacturing At Taj

Acamprosate Calcium

Clomipramine Hcl

Alendronate Sodium

Clonazepam

Amitriptyline

Clopidogrel Bisulfate

Anastrozole

Danazol

Atomoxetine Hcl

Desloratadine

Balsalazide

Desmopressin Monoacetate

Bicalutamide

Divalproex Sodium

Budesonide

Dobutamine Hcl

Bupropion Hcl

Donepezil

Calcitonin

Dothiepin Hcl

Capecitabine

Entacapone

Carbamazepine

Eptifibatide

Carboplatin

Escitalopram HBr

Carisoprodol

Eszopiclone

Carvedilol

Finasteride

Cefuroxime Axetil

Flurbiprofen

Cisplatin

Fluticasone Propionate

Citalopram Hbr

Fluvoxamine Maleate

Fosphenytoin Sodium

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.